Követés
Khalid Kamal
Khalid Kamal
West Virginia Univesity
E-mail megerősítve itt: hsc.wvu.edu
Cím
Hivatkozott rá
Hivatkozott rá
Év
A systematic review of quality of life instruments in long-term breast cancer survivors
I Chopra, KM Kamal
Health and quality of life outcomes 10, 1-15, 2012
2172012
Barriers and facilitators to shared decision-making in oncology: a systematic review of the literature
JR Covvey, KM Kamal, EE Gorse, Z Mehta, T Dhumal, E Heidari, D Rao, ...
Supportive Care in Cancer 27, 1613-1637, 2019
1552019
Determinants of adult influenza and pneumonia immunization rates
KM Kamal, SS Madhavan, MM Amonkar
Journal of the American Pharmacists Association 43 (3), 403-411, 2003
1202003
A systematic review of the effect of cancer treatment on work productivity of patients and caregivers
KM Kamal, JR Covvey, A Dashputre, S Ghosh, S Shah, M Bhosle, ...
Journal of managed care & specialty pharmacy 23 (2), 136-162, 2017
932017
Pharmacy and immunization services: pharmacists' participation and impact
KM Kamal, SS Madhavan, LL Maine
Journal of the American Pharmacists Association 43 (4), 470-482, 2003
852003
Stage of change and smoking cessation outcomes among adolescents
G Dino, K Kamal, K Horn, I Kalsekar, A Fernandes
Addictive Behaviors 29 (5), 935-940, 2004
702004
Use of tumor necrosis factor inhibitors in rheumatoid arthritis: a national survey of practicing United States rheumatologists
KM Kamal, SS Madhavan, JAA Hornsby, LA Miller, J Kavookjian, V Scott
Joint Bone Spine 73 (6), 718-724, 2006
582006
Community pharmacists and mental illness: a survey of service provision, stigma, attitudes and beliefs
V Giannetti, CF Caley, KM Kamal, JR Covvey, J McKee, BG Wells, ...
International journal of clinical pharmacy 40, 1096-1105, 2018
492018
Oral antidiabetic medication adherence and glycaemic control among patients with type 2 diabetes mellitus: a cross-sectional retrospective study in a tertiary hospital in Saudi …
B Balkhi, M Alwhaibi, N Alqahtani, T Alhawassi, TM Alshammari, ...
BMJ open 9 (7), e029280, 2019
412019
Using the theory of reasoned action to determine physicians' intention to measure body mass index in children and adolescents
R Khanna, J Kavookjian, VG Scott, KM Kamal, LAN Miller, WA Neal
Research in social and administrative pharmacy 5 (2), 170-181, 2009
382009
Evaluation of primary care physician chronic pain management practice patterns
D Provenzano, KM Kamal, V Giannetti
Pain Physician 21 (6), E593, 2018
322018
Barriers and facilitators to diabetes self-management in a primary care setting–Patient perspectives
R Khairnar, KM Kamal, V Giannetti, N Dwibedi, J McConaha
Research in Social and Administrative Pharmacy 15 (3), 279-286, 2019
302019
Impact of atrial fibrillation on inpatient cost for ischemic stroke in the USA
K Mukherjee, KM Kamal
International Journal of Stroke 14 (2), 159-166, 2019
282019
Factors that facilitate reporting of adverse drug reactions by pharmacists in Saudi Arabia
AY Aldryhim, A Alomair, M Alqhtani, MA Mahmoud, TM Alshammari, ...
Expert opinion on drug safety 18 (8), 745-752, 2019
252019
Asthma hospitalization risk and costs for patients treated with fluticasone propionate vs montelukast
L Orsini, S Limpa-Amara, WH Crown, RH Stanford, K Kamal
Annals of Allergy, Asthma & Immunology 92 (5), 523-529, 2004
232004
Adherence to statin therapy and attainment of LDL cholesterol goal among patients with type 2 diabetes and dyslipidemia
M Alwhaibi, M Altoaimi, Y AlRuthia, AM Meraya, B Balkhi, A Aldemerdash, ...
Patient preference and adherence, 2111-2118, 2019
222019
The impact of elective active-learning courses in pregnancy/lactation and pediatric pharmacotherapy
JP Elliott, PH Koerner, J Heasley, KM Kamal
American Journal of Pharmaceutical Education 76 (2), 26, 2012
222012
Primary care physician perspectives on barriers and facilitators to self-management of type 2 diabetes
R Khairnar, KM Kamal, V Giannetti, N Dwibedi, J McConaha
Journal of pharmaceutical health services research 10 (1), 117-123, 2019
202019
Sociodemographic determinants of out-of-pocket expenditures for patients using prescription drugs for rheumatoid arthritis
K Mukherjee, KM Kamal
American Health & Drug Benefits 10 (1), 7, 2017
202017
A required course in the development, implementation, and evaluation of clinical pharmacy services
ML Skomo, KM Kamal, HJ Berdine
American journal of pharmaceutical education 72 (5), 2008
202008
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20